Cerebral Palsy
Conditions
Keywords
gait, biomechanics
Brief summary
The aim of the study is to assess the impact of the innovative walking aid HIBBOT on the functions, activity and participation of young children with Cerebral Palsy, in comparison with conventional walking aids.
Interventions
DEVICEHIBBOT
Hibbot is an assistive mechanical device, lightweight and portable. The mechanism of the Hibbot manages to control all degrees of freedom (3x rotation and 3x translation) at the level of the pelvis and lower trunk. The goal is to maximize a child's own muscle activity and postural control while giving as minimal support as needed.
OTHERStandard Care
Standard care involves the standard physiotherapy the child would get during clinical care.
Sponsors
Universiteit Antwerpen
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Months to 6 Years
Healthy volunteers
No
Inclusion criteria
* At risk of or diagnosed with cerebral palsy, based on MRI (uCP 86 - 89 % sensitivity) or HINE (uCP 98% ) or standard motor assessment * age 18 months - 6 years * GMFCS level II - IV =with potential (=able to stand and walk when supported by a therapist at the level of the pelvis and lower trunk) * Sufficient cooperation to complete the tests.
Exclusion criteria
* Hip dysplasia * Fixed contractures in the lower limb * Botox infiltration \< 6 months prior to inclusion * Surgery \< 12 months prior to inclusion * Insufficient understanding of the interventon and tests (based on mental level assessment) * Refractary epilepsia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Lower limb kinematics during walking in degrees | baseline (at intake, T0) and after the intervention period (3 months, T1) | The gait pattern is assessed by instrumented 3D gait analysis. Joint rotation angles of the major joints of the lower limbs will be described during walking. |
| Change in Muscle activation patterns during gait in microvolts | baseline (at intake, T0) and after the intervention period (3 months, T1) | Surface electromyography signals will be recorded during gait |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Muscle activation patterns during gait in microvolts | at follow up (12 months after intake, T2) | Surface electromyography signals will be recorded during gait |
| Lower limb kinematics during walking in degrees | at follow up (12 months after intake, T2) | The gait pattern is assessed by instrumented 3D gait analysis. Joint rotation angles of the major joints of the lower limbs will be described during walking. |
Countries
Belgium
Outcome results
None listed